Signal Genetics Inc (SGNL)

[KoenigSalomon]

Signal Genetics (NASDAQ:SGNL) Files S-3 Statement - Signal Genetics has also filed a S-3 statement, which contains two prospectuses. The base prospectus covers the offering, issuance and sale of up to $50 million in the aggregate of the securities identified in a statement from time to time in one or more offerings. The sales agreement prospectus covers the offering, issuance and sale by SGNL of up to a maximum aggregate offering price of $4.45 million of its common stock that may be issued and sold under a sales agreement with Cantor Fitzgerald.